Diverse effect of fish oil on the growth of aberrant crypt foci and tumor multiplicity in F344 rats

Nutrition and Cancer

Volumn 31, Issue 3, 1998, Pages 204-211

  Good, Carolyn K ^a   Lasko, Catherine M ^a   Adam, Jay ^a   Bird, Ranjana P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CORN OIL; FISH OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON ADENOMA; CONTROLLED STUDY; FAT INTAKE; INTESTINE CRYPT; LIPID DIET; LOW FAT DIET; MALE; MULTIPLE CANCER; NONHUMAN; PRECANCER; RAT;

ANIMALIA; ZEA MAYS;

EID: 0031758106     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589809514704     Document Type: Article

References (26)

1. Neugart, AL, Garbowski, GC, Lee, WC, Murray, T, Nieves, JW, et al.: Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps: a case control study. Ann Intern Med 118, 91-95, 1993.
2. Potter, JD: Nutrition and colorectal cancer. Cancer Causes Control 7, 127-146, 1996.
3. Reddy, BS: Chemoprevention of colon cancer by dietary fatty acids. Cancer Metastasis Rev 13, 285-302, 1994.
4. Bird, RP: Observations and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37, 147-151, 1987.
5. McLellan, EA, and Bird, RP: Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 48, 6187-6192, 1988.
6. Bird, RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93, 55-71, 1995.
7. Wargovich, M, Chen, CD, Jimenez, A, Steele, VE, Velasco, M, et al.: Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5, 355-360, 1996.
8. Magnuson, BA, Shirtliff, N, and Bird, RP: Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid. Carcinogenesis 15, 1459-1462, 1994.
9. Bird, RP: Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon. Cancer Lett 88, 201-209, 1995.
10. Bird, RP, Yao, K, Lasko, CM, and Good, CK: Inability of low-or high-fat diet to modulate late stages of colon carcinogenesis in Sprague-Dawley rats. Cancer Res 56, 2896-2899, 1996.
11. Pence, BC, Dunn, DM, Zhao, C, Landers, M, and Wargovich, MJ: Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate end points. Carcinogenesis 16, 757-765, 1995.
12. Pretlow, TP, O'Riordan, MA, Pretlow, TG, and Stellate, TA: Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem Suppl 16G, 55-62, 1992.
13. American Institute of Nutrition: Report of the ad hoc committee on standards for nutritional studies. J Nutr 107, 1340-1348, 1977.
14. Lasko, CM, and Bird, RP: Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention. Cancer Epidemiol Biomarkers Prev 4, 49-55, 1995.
15. Yao, K, Lasko, C, and Bird, RP: Modulating role of dietary fat, energy restriction, and the effect of age on the expression of proliferating cell nuclear antigen and protein kinase C activity in prostate glands of rat. Nutr Biochem 9, 236-241, 1998.
16. Sumida, C, Graber, R, and Nunez, E: Role of fatty acids in signal transduction: modulators and messengers. Prostaglandins Leukotr Essent Fatty Acids 48, 117-122, 1993.
17. Clandinin, MT, Cheema, S, Field, CJ, Garg, ML, Venkatraman, J, et al.: Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5, 2761-2769, 1991.
18. Culp, BR, Titus, BJ, and Lands, WE: Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid. Prostaglandins Med 3, 269-278, 1979.
19. Fischer, S: Dietary polyunsaturated fatty acids and eicosanoid formation in humans. Adv Lipid Res 23, 169-198, 1989.
20. Corey, EJ, Chih, C, and Cashman, JR: Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 80, 3581-3584, 1983.
21. Anti, M, Armelao, F, Marra, G, Percesepe, A, Bartoli, GM, et al.: Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonie adenomas. Gastroenterology 107, 1709-1718, 1994.
22. 2 release in healthy subjects. Gastroenterology 105, 1317-1322, 1993.
23. 2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res 56, 412-517, 1996.
24. Giardiello, FM, Hamilton, SR, Krush, AJ, Piantadosi, S, Hylind, LM, et al.: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328, 1313-1316, 1993.
25. Reddy, BS, Rao, CV, and Seibert, K: Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56, 4566-4569, 1996.
26. Sandler, RS: Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer. Important Adv Oncol 45, 123-127, 1996.